Skip to main content
SpringerLink
Log in

Neuroprotection in Cerebrovascular Disease

  • Protocol
  • First Online:
The Handbook of Neuroprotection

Part of the book series: Springer Protocols Handbooks ((SPH))

  • 900 Accesses

Abstract

Cerebrovascular disease is the term applied to many diseases with pathology in the blood vessels of the brain or the vessels supplying blood to the brain. A simplified classification of cerebrovascular diseases where neuroprotection is required is shown in Table 3.1.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Albers GW, Marks MP, Kemp S, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med 2018;378:708–18.

    Article  PubMed  PubMed Central  Google Scholar 

  • Al-Jamal KT, Gherardini L, Bardic G, et al. Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing. Proc Natl Acad Sci U S A 2011;108:10952–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Allahtavakoli M, Kahnouei MH, Rezazadeh H. Delayed combination therapy of local brain hypothermia and decompressive craniectomy on acute stroke outcome in rat. Iran J Basic Med Sci 2014;17:476–82.

    PubMed  PubMed Central  Google Scholar 

  • Amarenco P, Albers GW, Denison H, et al. Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial. Lancet Neurol 2017;16:301–10.

    Article  CAS  PubMed  Google Scholar 

  • Amarenco P, Lavallée PC, Monteiro Tavares L, et al. Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke. N Engl J Med 2018;378:2182–90.

    Article  PubMed  Google Scholar 

  • Amaro S, Laredo C, Renú A, et al. Uric Acid Therapy Prevents Early Ischemic Stroke Progression: A Tertiary Analysis of the URICO-ICTUS Trial (Efficacy Study of Combined Treatment With Uric Acid and r-tPA in Acute Ischemic Stroke). Stroke 2016;47:2874–6.

    Article  CAS  PubMed  Google Scholar 

  • Amiri-Nikpour MR, Nazarbaghi S, Hamdi-Holasou M, Rezaei Y. An open-label evaluator-blinded clinical study of minocycline neuroprotection in ischemic stroke: gender-dependent effect. Acta Neurol Scand 2015;131:45-50Arac et al 2011

    Article  CAS  PubMed  Google Scholar 

  • Antithrombotic Trialists’ (ATT) Collaboration, Baigent C, Blackwell L, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;373:1849–60.

    Google Scholar 

  • Arac A, Brownell SE, Rothbard JB, et al. Systemic augmentation of αB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation. PNAS 2011;108:13287–92.

    Article  CAS  Google Scholar 

  • Arboix A, Garcia-Eroles L, Oliveres M, et al. Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia? BMC Neurology 2010;10:47.

    Google Scholar 

  • Arikan F, Vilalta J, Torne R, et al. Rapid Resolution of Brain Ischemic Hypoxia After Cerebral Revascularization in Moyamoya Disease. Neurosurgery 2015;76:302–12.

    Article  PubMed  Google Scholar 

  • Arumugam TV, Tang SC, Lathia JD, et al. Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death. PNAS 2007;104:14104–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Aslami H, Schultz MJ, Juffermans NP. Potential applications of hydrogen sulfide-induced suspended animation. Curr Med Chem 2009;16:1295–1303.

    Article  CAS  PubMed  Google Scholar 

  • Badin RA, Modo M, Cheetham M, et al. Protective effect of post-ischaemic viral delivery of heat shock proteins in vivo. J Cereb Blood Flow Metab 2009;29:254–63.

    Article  CAS  PubMed  Google Scholar 

  • Balestrino M, Sarocchi M, Adriano E, Spallarossa P. Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease. Amino Acids 2016;48:1955–67.

    Article  CAS  PubMed  Google Scholar 

  • Bargiotas P, Krenz A, Hormuzdi SG, et al. Pannexins in ischemia-induced neurodegeneration. PNAS 2011;108:20772–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bath PM, Krishnan K, Appleton JP. Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke. Cochrane Database Syst Rev 2017;4:CD000398.

    Google Scholar 

  • Belayev L, Khoutorova L, Atkins KD, et al. Docosahexaenoic Acid therapy of experimental ischemic stroke. Transl Stroke Res 2011;2:33–41.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015;372:11–20.

    Article  CAS  PubMed  Google Scholar 

  • Bravi L, Rudini N, Cuttano R, et al. Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice. Proc Natl Acad Sci U S A 2015;112:8421–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brotfain E, Kutz R, Grinshpun J, et al. Blood Glutamate Reducing Effect of Hemofiltration in Critically Ill Patients. Neurotox Res 2018;33:300–308.

    Article  CAS  PubMed  Google Scholar 

  • Brott TG, Howard G, Roubin GS, et al. Long-term results of stenting versus endarterectomy for carotid-artery stenosis. N Engl J Med 2016; 374:1021–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection. NEJM 2015;372:1009–18.

    Article  CAS  PubMed  Google Scholar 

  • Carloni S, Girelli S, Buonocore G, et al. Simvastatin acutely reduces ischemic brain damage in the immature rat via Akt and CREB activation. Exp Neurol 2009;220:82–9.

    Article  CAS  PubMed  Google Scholar 

  • Carpenter CR, Keim SM, Crossley J, Perry JJ. Post-transient ischemic attack early stroke stratification: the ABCD(2) prognostic aid. J Emerg Med 2009;36:194–198.

    Article  PubMed  Google Scholar 

  • Casas AI, Geuss E, Kleikers PWM, et al. NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damage. Proc Natl Acad Sci U S A 2017;114:12315–12320.

    Article  CAS  Google Scholar 

  • Chaturvedi M, Kaczmarek L. Mmp-9 inhibition: a therapeutic strategy in ischemic stroke. Mol Neurobiol 2014;49:563–73.

    Article  CAS  PubMed  Google Scholar 

  • Chen X, Arumugam TV, Cheng YL, et al. Combination Therapy with Low-Dose IVIG and a C1-esterase Inhibitor Ameliorates Brain Damage and Functional Deficits in Experimental Ischemic Stroke. Neuromolecular Med 2018;20:63–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis. NEJM 2011;365:993–1003.

    Article  CAS  PubMed  Google Scholar 

  • Chollet F, Tardy J, Albucher JF, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 2011;10:123–30.

    Article  CAS  PubMed  Google Scholar 

  • Clark WM. Efficacy of citicoline as an acute stroke treatment. Expert Opin Pharmacother 2009;10:839–46.

    Article  CAS  PubMed  Google Scholar 

  • Connolly SJ, Eikelboom J, Joyner C, et al. Apixaban in Patients with Atrial Fibrillation. NEJM 2011;364:806–17.

    Article  CAS  PubMed  Google Scholar 

  • Davis SM, Donnan GA. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack. N Engl J Med 2012;366:1914–22.

    Article  CAS  PubMed  Google Scholar 

  • Dengler R, Diener HC, Schwartz A, et al. Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial. Lancet Neurol 2010;9:159–66.

    Article  CAS  PubMed  Google Scholar 

  • Diener HC, Schneider D, Lampl Y, et al. DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke. Stroke 2008;39:1774–8.

    Article  CAS  PubMed  Google Scholar 

  • Diener HC, Connolly SJ, Ezekowitz MD, et al; for the RE-LY study group. Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial. Lancet Neurol 2010;9:1157–63.

    Article  CAS  PubMed  Google Scholar 

  • Digicaylioglu M. Erythropoietin in stroke: quo vadis. Expert Opin Biol Ther 2010;10:937–49.

    Article  CAS  PubMed  Google Scholar 

  • Doeppner TR, Kaltwasser B, Sanchez-Mendoza EH, et al. Lithium-induced neuroprotection in stroke involves increased miR-124 expression, reduced RE1-silencing transcription factor abundance and decreased protein deubiquitination by GSK3β inhibition-independent pathways. J Cereb Blood Flow Metab 2017;37:914–926.

    Article  CAS  PubMed  Google Scholar 

  • Donnan GA. The 2007 Feinberg lecture: a new road map for neuroprotection. Stroke 2008;39:242.

    Article  PubMed  Google Scholar 

  • Dunn DE, He DN, Yang P, et al. In vitro and in vivo neuroprotective activity of the cardiac glycoside oleandrin from Nerium oleander in brain slice-based stroke models. J Neurochem 2011;119:805–14.

    Article  CAS  PubMed  Google Scholar 

  • Elmaraezy A, Abushouk AI, Saad S, et al. Desmoteplase for Acute Ischemic Stroke: A Systematic Review and Metaanalysis of Randomized Controlled Trials. CNS Neurol Disord Drug Targets 2017;16:789–799.

    Article  CAS  PubMed  Google Scholar 

  • Elzer JG, Muhammad S, Wintermantel TM, et al. Neuronal estrogen receptor-alpha mediates neuroprotection by 17beta-estradiol. J Cereb Blood Flow Metab 2010;30:935–42.

    Google Scholar 

  • Fletcher L, Kohli S, Sprague SM, et al. Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. Laboratory investigation. J Neurosurg 2009;111:164–70.

    Article  CAS  PubMed  Google Scholar 

  • Gleeson LC, Ryan KJ, Griffin EW, et al. The beta(2)-adrenoceptor agonist clenbuterol elicits neuroprotective, anti-inflammatory and neurotrophic actions in the kainic acid model of excitotoxicity. Brain Behav Immun 2010;24:1354–61.

    Article  CAS  PubMed  Google Scholar 

  • Goldstein LB, Amarenco P, Zivin J, et al.; Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators. Statin treatment and stroke outcome in the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Stroke 2009;40:3526–3531.

    Article  CAS  PubMed  Google Scholar 

  • Goossens J, Hachimi-Idrissi S. Combination of therapeutic hypothermia and other neuroprotective strategies after an ischemic cerebral insult. Curr Neuropharmacol 2014;12:399–412.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015;372:1019–30.

    Article  CAS  PubMed  Google Scholar 

  • Gross BA, Du R. Hemorrhage from cerebral cavernous malformations: a systematic pooled analysis. J Neurosurg 2017;126:1079–87.

    Article  PubMed  Google Scholar 

  • Gupta R, Tayal A, Levy E, et al. Intra-arterial Thrombolysis or Stent Placement During Endovascular Treatment for Acute Ischemic Stroke Leads to the Highest Recanalization Rate: Results of a Multicenter Retrospective Study. Neurosurgery 2011;68: 1618–23.

    Article  PubMed  Google Scholar 

  • Haghnejad Azar A, Oryan S, Bohlooli S, Panahpour H. Alpha-Tocopherol Reduces Brain Edema and Protects Blood-Brain Barrier Integrity following Focal Cerebral Ischemia in Rats. Med Princ Pract 2017;26:17–22.

    Article  PubMed  Google Scholar 

  • Hao Z, Chang X, Zhou H, et al. A Cohort Study of Decompressive Craniectomy for Malignant Middle Cerebral Artery Infarction: A Real-World Experience in Clinical Practice. Medicine (Baltimore) 2015;94:e1039.

    Article  Google Scholar 

  • Harraz MM, Eacker SM, Wang X, et al. MicroRNA-223 is neuroprotective by targeting glutamate receptors. Proc Natl Acad Sci U S A 2012;109:18962–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hart RG, Sharma M, Mundl H, et al. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. N Engl J Med 2018; 378:2191–2201.

    Article  CAS  PubMed  Google Scholar 

  • Hentia C, Rizzato A, Camporesi E, et al. An overview of protective strategies against ischemia/reperfusion injury: The role of hyperbaric oxygen preconditioning. Brain Behav 2018;8:e00959.

    Article  PubMed  PubMed Central  Google Scholar 

  • Heurteaux C, Gandin C, Borsotto M, et al. Neuroprotective and neuroproliferative activities of NeuroAid (MLC601, MLC901), a Chinese medicine, in vitro and in vivo. Neuropharmacology 2010;58:987–1001.

    Article  CAS  PubMed  Google Scholar 

  • Hill MD, Martin RH, Mikulis D, et al. Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2012;11:942–50.

    Article  CAS  PubMed  Google Scholar 

  • Holbach KH, Wassmann H, Hohelüchter KL, Jain KK. Differentiation between reversible and irreversible post-stroke changes in the brain tissue and its relevance to cerebrovascular surgery. Surg Neurol 1977;7:324–31.

    Google Scholar 

  • Hong KS, Lee JS. Statins in Acute Ischemic Stroke: A Systematic Review. J Stroke 2015;17:282–301.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ishida K, Berger M, Nadler J, Warner DS. Anesthetic neuroprotection: antecedents and an appraisal of preclinical and clinical data quality. Curr Pharm Des 2014;20:5751–65.

    Article  CAS  PubMed  Google Scholar 

  • Jain KK. Sutureless microvascular anastomosis using Nd:YAG laser. J Microsurgery 1980;1:436–9.

    Article  CAS  Google Scholar 

  • Jain KK. Hyperbaric oxygen therapy in neurosurgery. In, Jain KK. Textbook of Hyperbaric Medicine, 6th ed. Springer, New York 2017.

    Chapter  Google Scholar 

  • Jain KK. Cell Therapy: technologies, companies and markets. Jain PharmaBiotech Publications, Basel, 2019a.

    Google Scholar 

  • Jain KK. Hyperbaric oxygenation for the treatment of stroke. In, Roos RP (ed) MedLink Neurology. Medlink Publishing Corporation, San Diego, California, 2019b.

    Google Scholar 

  • Jäkälä P, Jolkkonen J. Time for a neurorestorative therapy in stroke. Expert Opin Biol Ther 2012;12:267–70.

    Article  PubMed  CAS  Google Scholar 

  • Jefferis BJ, Whincup PH, Papacosta O, Wannamethee SG. Protective effect of time spent walking on risk of stroke in older men. Stroke 2014;45:194–9.

    Article  PubMed  Google Scholar 

  • Ji Y, Teng L, Zhang R, et al. NRG-1β exerts neuroprotective effects against ischemia reperfusion-induced injury in rats through the JNK signaling pathway. Neuroscience 2017;362:13–24.

    Article  CAS  PubMed  Google Scholar 

  • Jiang J, Ganesh T, Du Y, et al. Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor. PNAS 2010;107:2307–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jiang J, Ganesh T, Du Y, et al. Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2. Proc Natl Acad Sci U S A 2012;109:3149–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med 2019;379:215–225.

    Article  Google Scholar 

  • Jovin TG, Chamorro TG, Cobo E. Thrombectomy within 8 hours after symptom onset in ischemic stroke. NEJM 2015;372:2296–306.

    Article  CAS  PubMed  Google Scholar 

  • Karsy M, Brock A, Guan J, et al. Neuroprotective strategies and the underlying molecular basis of cerebrovascular stroke. Neurosurg Focus 2017;42(4):E3.

    Article  PubMed  Google Scholar 

  • Kelly P, Prabhakaran S. Statins for Neuroprotection After Acute Ischemic Stroke: ASSORTed Results But More Trials Needed. Stroke 2017;48:2922–2923.

    Article  PubMed  Google Scholar 

  • Kernan WN, Viscoli CM, Furie KL, et al. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack. N Engl J Med 2016;374:1321–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Khodanovich M, Kisel A, Kudabaeva M, et al. Effects of Fluoxetine on Hippocampal Neurogenesis and Neuroprotection in the Model of Global Cerebral Ischemia in Rats. Int J Mol Sci 2018;19:pii: E162.

    Article  PubMed Central  CAS  Google Scholar 

  • Kim GH, Kellner CP, Hickman ZL, et al. A phase I clinical trial of tiopronin, a putative neuroprotective agent, in aneurysmal subarachnoid hemorrhage. Neurosurgery 2010;67:182–6.

    Article  PubMed  Google Scholar 

  • Kinouchi T, Kitazato KT, Shimada K, et al. Treatment with the PPARγ Agonist Pioglitazone in the Early Post-ischemia Phase Inhibits Pro-inflammatory Responses and Promotes Neurogenesis Via the Activation of Innate- and Bone Marrow-Derived Stem Cells in Rats. Transl Stroke Res 2018;9:306–316.

    Article  CAS  PubMed  Google Scholar 

  • Korde AS, Pettigrew LC, Craddock SD, et al. Protective effects of NIM811 in transient focal cerebral ischemia suggest involvement of the mitochondrial permeability transition. J Neurotrauma 2007;24:895–908.

    Article  PubMed  Google Scholar 

  • Kotani Y, Shimazawa M, Yoshimura S, Iwama T, Hara H. The Experimental and Clinical Pharmacology of Propofol, an Anesthetic Agent with Neuroprotective Properties. CNS Neuroscience & Therapeutics 2008;14:95–106.

    Article  CAS  Google Scholar 

  • Kunz A, Park L, Abe T, et al. Neurovascular protection by ischemic tolerance: role of nitric oxide and reactive oxygen species. J Neurosci 2007;27:7083–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lampl Y, Boaz M, Gilad R, et al. Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 2007;69:1404–10.

    Article  CAS  PubMed  Google Scholar 

  • Lapchak PA. Neuroprotective and neurotrophic curcuminoids to treat stroke: a translational perspective. Expert Opinion Invest Drugs 2011;20:13–22.

    Article  CAS  Google Scholar 

  • Lapchak PA, Boitano PD. Transcranial Near-Infrared Laser Therapy for Stroke: How to Recover from Futility in the NEST-3 Clinical Trial. Acta Neurochir Suppl 2016;121:7–12.

    Article  PubMed  Google Scholar 

  • Leclerc JL, Lampert AS, Diller MA, et al. Prostaglandin E2 EP2 receptor deletion attenuates intracerebral hemorrhage-induced brain injury and improves functional recovery. ASN Neuro 2015;7(2); pii: 1759091415578713.

    Article  CAS  Google Scholar 

  • Lee B, Clarke D, Al Ahmad A, et al. Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents. J Clin Invest 2011;121:3005–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Levy EI, Rahman M, Khalessi AA, et al. Midterm Clinical and Angiographic Follow-Up for the First Food and Drug Administration-Approved Prospective, Single-Arm Trial of Primary Stenting for Stroke: SARIS (Stent-Assisted Recanalization for Acute Ischemic Stroke). Neurosurgery 2011;69:915–20.

    Google Scholar 

  • Li Q, Zhuang QK, Yang JN, Zhang YY. Statins excert neuroprotection on cerebral ischemia independent of their lipid-lowering action: the potential molecular mechanisms. Eur Rev Med Pharmacol Sci 2014;18:1113–26.

    Google Scholar 

  • Li S, Hafeez A, Noorulla F, et al. Preconditioning in neuroprotection: From hypoxia to ischemia. Prog Neurobiol 2017;157:79–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liu J, Wang LN. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack. Cochrane Database Syst Rev 2017;12:CD010693.

    Google Scholar 

  • Liu K, Mori S, Takahashi HK, Tomono Y, et al. Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J 2007;21:3904–16.

    Article  CAS  PubMed  Google Scholar 

  • Liu Y, Wang S, Luo S, et al. Intravenous PEP-1-GDNF is protective after focal cerebral ischemia in rats. Neurosci Lett 2016;617:150–5.

    Article  CAS  PubMed  Google Scholar 

  • Lockman JA, Geldenhuys WJ, Bohn KA, et al. Differential effect of nimodipine in attenuating iron-induced toxicity in brain- and blood-brain barrier-associated cell types. Neurochem Res 2012;37:134–42.

    Article  PubMed  CAS  Google Scholar 

  • McDonough A, Weinstein JR. Neuroimmune Response in Ischemic Preconditioning. Neurotherapeutics 2018;15:511–524.

    Article  PubMed  Google Scholar 

  • Mead G, Hackett ML, Lundström E, et al. The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: a study protocol for three multicentre randomised controlled trials. Trials 2015;16:369.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Motyer R, Asadi H, Thornton J, et al. Current evidence for endovascular therapy in stroke and remaining uncertainties. J Intern Med 2018;283:2–15.

    Article  CAS  PubMed  Google Scholar 

  • Nakase T, Yoshioka S, Suzuki A. Free radical scavenger, edaravone, reduces the lesion size of lacunar infarction in human brain ischemic stroke. BMC Neurology 2011;11:39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nalamolu KR, Smith NJ, Chelluboina B, et al. Prevention of the Severity of Post-ischemic Inflammation and Brain Damage by Simultaneous Knockdown of Toll-like Receptors 2 and 4. Neuroscience 2018;373:82–91.

    Article  CAS  PubMed  Google Scholar 

  • Nemati R, Dietz C, Anstadt EJ, et al. Deposition and hydrolysis of serine dipeptide lipids of Bacteroidetes bacteria in human arteries: relationship to atherosclerosis. J Lipid Res 2017;58:1999–2007.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Niimi M, Hashimoto K, Kakuda W, et al. Role of brain-derived neurotrophic factor in beneficial effects of repetitive transcranial magnetic stimulation for upper limb hemiparesis after stroke. PLoS One 2016;11:e0152241.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Nakajima M, Suda S, Sowa K, et al. AMPA Receptor Antagonist Perampanel Ameliorates Post-Stroke Functional and Cognitive Impairments. Neuroscience 2018;386:256–264.

    Article  CAS  PubMed  Google Scholar 

  • Nikolaev SI, Vetiska S, Bonilla X, et al. Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain. N Engl J Med 2018;378:250–261.

    Google Scholar 

  • Nishimura S, Mishra-Gorur K, Park JS, et al. Combined HMG-COA reductase and prenylation inhibition in treatment of CCM. Proc Natl Acad Sci U S A 2017;114:5503–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Okoreeh AK, Bake S, Sohrabji F. Astrocyte-specific insulin-like growth factor-1 gene transfer in aging female rats improves stroke outcomes. Glia 2017;65:1043–1058.

    Article  PubMed  PubMed Central  Google Scholar 

  • Overman JJ, Clarkson AN, Wanner IB, et al. A role for ephrin-A5 in axonal sprouting, recovery, and activity-dependent plasticity after stroke. Proc Natl Acad Sci U S A 2012;109:E2230–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Paciaroni M, Caso V, Agnelli G. The concept of ischemic penumbra in acute stroke and therapeutic opportunities. Eur Neurol 2009;61:321–30.

    Article  PubMed  Google Scholar 

  • Papadakis M, Hadley G, Xilouri M, et al. Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy. Nat Med 2013;19:351–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Park HA, Kubicki N, Gnyawali S, et al. Natural vitamin E α-tocotrienol protects against ischemic stroke by induction of multidrug resistance-associated protein 1. Stroke 2011;42:2308–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Polster SP, Stadnik A, Akers AL, et al. Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial. Neurosurgery 2018 Nov 26; doi:https://doi.org/10.1093/neuros/nyy539. [Epub ahead of print]

  • Ramos-Cejudo J, Gutiérrez-Fernández M, Otero-Ortega L, et al. Brain-derived neurotrophic factor administration mediated oligodendrocyte differentiation and myelin formation in subcortical ischemic stroke. Stroke 2015;46:221–8.

    Article  CAS  PubMed  Google Scholar 

  • Ringelstein EB, Thijs V, Norrving B, et al. Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke 2013;44:2681–7.

    Article  CAS  PubMed  Google Scholar 

  • Rink C, Christoforidis G, Khanna S, et al. Tocotrienol vitamin E protects against preclinical canine ischemic stroke by inducing arteriogenesis. J Cereb Blood Flow Metab 2011; 31:2218–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rosenfield K, Matsumura JS, Chaturvedi S, et al. Randomized trial of stent versus surgery for asymptomatic carotid stenosis. N Engl J Med 2016;374:1011–20.

    Article  CAS  PubMed  Google Scholar 

  • Ryou MG, Choudhury GR, Li W, et al. Methylene blue-induced neuronal protective mechanism against hypoxia-reoxygenation stress. Neuroscience 2015;301:193–203.

    Article  CAS  PubMed  Google Scholar 

  • Sakurazawa M, Katsura K, Saito, M, et al. Mild hypothermia enhanced the protective effect of protein therapy with transductive anti-death FNK protein using a rat focal transient cerebral ischemia model. Brain Res 2012;1430:86–92.

    Article  CAS  PubMed  Google Scholar 

  • Saver JL, Starkman S, Eckstein M, et al. Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N Engl J Med 2015;372:528–36.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Saver JL, Goyal M, Bonafe A, et al. Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke. N Engl J Med 2015a;372:2285–95.

    Article  CAS  PubMed  Google Scholar 

  • Shah ZA, Li RC, Ahmad AS, et al. The flavanol (−)-epicatechin prevents stroke damage through the Nrf2/HO1 pathway. J Cereb Blood Flow Metab 2010;30:1951–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sheng SP, Lei B, James ML, et al. Xenon neuroprotection in experimental stroke: interactions with hypothermia and intracerebral hemorrhage. Anesthesiology 2012;117:1262–75.

    Article  CAS  PubMed  Google Scholar 

  • Shenkar R, Shi C, Austin C, et al. RhoA kinase inhibition with fasudil versus simvastatin in murine models of cerebral cavernous malformations. Stroke 2017;48:187–194.

    Article  CAS  PubMed  Google Scholar 

  • Shih AY, Friedman B, Drew PJ, et al. Active dilation of penetrating arterioles restores red blood cell flux to penumbral neocortex after focal stroke. J Cereb Blood Flow Metab 2009;29:738–51.

    Article  PubMed  Google Scholar 

  • Shimada Y, Tsunoda H, Zang L, et al. Synergistic induction of heme oxygenase-1 by nicaraven after subarachnoid hemorrhage to prevent delayed cerebral vasospasm. Eur J Pharmacol 2009;620:16–20.

    Article  CAS  PubMed  Google Scholar 

  • Siepmann T, Penzlin AI, Kepplinger J, et al: Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence. Brain Behav 2015;5:e00373.

    Article  PubMed  PubMed Central  Google Scholar 

  • Silver B, McCarthy S, Lu M, et al. Sildenafil treatment of subacute ischemic stroke: a safety study at 25-mg daily for 2 weeks. J Stroke Cerebrovasc Dis 2009;18:381–3.

    Article  PubMed  Google Scholar 

  • Simmons LJ, Surles-Zeigler MC, et al. Li Y, Regulation of inflammatory responses by neuregulin-1 in brain ischemia and microglial cells in vitro involves the NF-kappa B pathway. J Neuroinflammation 2016;13:237.

    Google Scholar 

  • Stanne TM, Ã…berg ND, Nilsson S, et al. Low circulating acute brain-derived neurotrophic factor levels are associated with poor long-term functional outcome after ischemic stroke. Stroke 2016;47:1943–5.

    Article  CAS  PubMed  Google Scholar 

  • Subic A, Cermakova P, Norrving B, et al. Management of acute ischaemic stroke in patients with dementia. J Intern Med 2017;281:348–364.

    Article  CAS  PubMed  Google Scholar 

  • Svalbe B, Zvejniece L, Vavers E, et al. Mildronate treatment improves functional recovery following middle cerebral artery occlusion in rats. Behav Brain Res 2011;222:26–32.

    Article  CAS  PubMed  Google Scholar 

  • Tameh AA, Karimian M, Zare-Dehghanani Z, et al. Role of Steroid Therapy after Ischemic Stroke by n-Methyl-d-Aspartate Receptor Gene Regulation. J Stroke Cerebrovasc Dis 2019;27:3066–3075.

    Article  Google Scholar 

  • Teramoto S, Miyamoto N, Yatomi K, et al. Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia. J Cereb Blood Flow & Met 2011;31:1696–705.

    Article  CAS  Google Scholar 

  • Tseng MY, Hutchinson PJ, Richards HK, et al. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. Clinical article. J Neurosurg 2009;111:171–80.

    Article  CAS  PubMed  Google Scholar 

  • Tymianski M. Combining Neuroprotection With Endovascular Treatment of Acute Stroke: Is There Hope? Stroke 2017;48:1700–1705.

    Article  PubMed  Google Scholar 

  • Vajda Z, Schmid E, Güthe T, et al. The modified Bose-method for the endovascular treatment of intracranial atherosclerotic arterial stenoses using the Enterprise stent. Neurosurgery 2011;70:91–101.

    Article  Google Scholar 

  • Venketasubramanian N, Young SH, Tay SS, et al; CHIMES-E Study Investigators. CHInese Medicine NeuroAiD Efficacy on Stroke Recovery - Extension Study (CHIMES-E): A Multicenter Study of Long-Term Efficacy.Cerebrovasc Dis 2015;39:309–18.

    Google Scholar 

  • Wahlgren N, Thorén M, Höjeberg B, et al. Randomized assessment of imatinib in patients with acute ischaemic stroke treated with intravenous thrombolysis. J Intern Med 2017;281:273–83.

    Article  CAS  PubMed  Google Scholar 

  • Wang J, Jiang C, Liu C, et al. Neuroprotective effects of progesterone following stroke in aged rats. Behav Brain Res 2010;209:119–22.

    Article  CAS  PubMed  Google Scholar 

  • Wang B, Zhu X, Kim Y, et al. Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage. Free Radic Biol Med 2012;52:928–36.

    Article  CAS  PubMed  Google Scholar 

  • Whitehead KJ, Chan AC, Navankasattusas S, et al. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med 2009;15:177–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Williams JJ, Mayurasakorn K, Vannucci SJ, et al. N-3 fatty acid rich triglyceride emulsions are neuroprotective after cerebral hypoxic-ischemic injury in neonatal mice. PLoS One 2013;8:e56233.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wu W, Asakawa T, Yang Q, et al. Effects of neuroserpin on clinical outcomes and inflammatory markers in Chinese patients with acute ischemic stroke. Neurol Res 2017;39:862–868.

    Article  CAS  PubMed  Google Scholar 

  • Yang C, Zhang X, Fan H, Liu Y. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res 2009;1282:133–41.

    Article  CAS  PubMed  Google Scholar 

  • Yoon W, Kim BM, Kim DJ, et al. Outcomes and Prognostic Factors After Emergent Carotid Artery Stenting for Hyperacute Stroke Within 6 Hours of Symptom Onset. Neurosurgery 2015;76:321–9.

    Article  PubMed  Google Scholar 

  • Yoshimura S, Uchida K, Daimon T, et al. Randomized controlled trial of early versus delayed statin therapy in patients with acute ischemic stroke: ASSORT trial (Administration of Statin on Acute Ischemic Stroke Patient). Stroke 2017;48:3057–3063.

    Article  CAS  PubMed  Google Scholar 

  • Zhang GL, Wang LH, Liu XY, et al. Cerebral Dopamine Neurotrophic Factor (CDNF) Has Neuroprotective Effects against Cerebral Ischemia That May Occur through the Endoplasmic Reticulum Stress Pathway. Int J Mol Sci 2018;19(7):1905.

    Article  PubMed Central  CAS  Google Scholar 

  • Zhang ZY, Sun BL, Yang MF, et al. Carnosine attenuates early brain injury through its antioxidative and anti-apoptotic effects in a rat experimental subarachnoid hemorrhage model. Cell Mol Neurobiol 2015;35:147–57.

    Article  PubMed  CAS  Google Scholar 

  • Zhao Y, Adjei AA. The clinical development of MEK inhibitors. Nat Rev Clin Oncol 2014;11:385–400.

    Article  CAS  PubMed  Google Scholar 

  • Zhao J, Yu S, Zheng W, et al. Curcumin improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Neurochem Res 2010;35:374–9.

    Article  CAS  PubMed  Google Scholar 

  • Zhao JJ, Song JQ, Pan SY, Wang K. Treatment with Isorhamnetin Protects the Brain Against Ischemic Injury in Mice. Neurochem Res 2016;41:1939–48.

    Article  CAS  PubMed  Google Scholar 

  • Zhou Z, Tang AT, Wong WY, et al. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling. Nature 2016;532:122–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhu YM, Wang CC, Chen L, et al. Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats. Brain Res 2013;1494:1–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Jain PharmaBiotech, Basel, Switzerland

    Kewal K. Jain

Authors
  1. Kewal K. Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Jain, K.K. (2019). Neuroprotection in Cerebrovascular Disease. In: The Handbook of Neuroprotection. Springer Protocols Handbooks. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9465-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-9465-6_3

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-4939-9464-9

  • Online ISBN: 978-1-4939-9465-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation